Cisplatin






14680 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 75760 Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Cancer 1978 Feb 1
2 121143 [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)]. Klin Wochenschr 1979 Dec 3 1
3 469203 [The value of cis-diamminedichloroplatinum (cis-platinum) CDDP in the treatment of stage III and IV cancers of the ovary (author's transl)]. J Gynecol Obstet Biol Reprod (Paris) 1979 Jan-Feb 2
4 1281446 The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. Cancer Chemother Pharmacol 1992 1
5 1282775 [Successful management of choriocarcinoma of the testis with brain metastasis: a case report]. Hinyokika Kiyo 1992 Oct 1
6 1286156 Protein kinase C modulation. Semin Cancer Biol 1992 Dec 1
7 1289495 Disulfide bond cleavage of human fibrinogen by cis-diamminedichloroplatinum(II). J Pharmacobiodyn 1992 Nov 6
8 1291340 [A case of esophageal carcinoma with hypercalcemia caused by PTH-rP--the effect of therapy on the bone and calcium metabolism]. Nihon Naibunpi Gakkai Zasshi 1992 Dec 20 1
9 1306884 Use of GM-CSF in children after high-dose chemotherapy. Med Pediatr Oncol Suppl 1992 1
10 1309303 Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer 1992 Jan 1 1
11 1310490 Increased phosphorylation of nuclear phosphoproteins in human lung-cancer cells resistant to cis-diamminedichloroplatinum (II). Int J Cancer 1992 Feb 1 4
12 1311914 [Effect of lipiodol-cisplatinum arterial infusion chemotherapy on cellular immunity]. Gan To Kagaku Ryoho 1992 Mar 1
13 1314712 Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer. Cancer Chemother Pharmacol 1992 1
14 1314713 The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278. Cancer Chemother Pharmacol 1992 2
15 1315778 Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines. J Cancer Res Clin Oncol 1992 1
16 1316774 A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines. Br J Cancer 1992 May 1
17 1318287 Cisplatin neuropathy in brain tumor chemotherapy. Ital J Neurol Sci 1992 May 1
18 1319424 A new, semi-automated system for the micro-scale synthesis of [195mPt]cisplatin suitable for clinical studies. Int J Rad Appl Instrum A 1992 Jun 2
19 1321636 Effects of cisplatin on human thyrocytes in monolayer or follicle culture. J Mol Endocrinol 1992 Jun 3
20 1323213 Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992 Aug 2
21 1323324 Double-blind, randomized trial for the control of delayed emesis in patients receiving cisplatin: comparison of placebo vs. adrenocorticotropic hormone (ACTH). Ann Oncol 1992 Jun 1
22 1323814 Platinum/oral etoposide therapy in non-small cell lung cancer. Oncology 1992 1
23 1326318 ACTH/MSH like peptides in the treatment of cisplatin neuropathy. J Steroid Biochem Mol Biol 1992 Sep 4
24 1326334 Inhibition of different steps of the ubiquitin system by cisplatin and aclarubicin. Biochim Biophys Acta 1992 Sep 15 7
25 1327513 Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin. Cancer Res 1992 Oct 15 4
26 1329216 Clinical experiences with carboplatin (paraplatin) in lung cancer. Semin Oncol 1992 Feb 2
27 1329884 Biochemical modification of the toxicity and the anti-tumour effect of 5-fluorouracil and cis-platinum by WR-2721 in mice. Eur J Cancer 1992 2
28 1330594 Cisplatin-induced conditioned taste aversion: attenuation by dexamethasone but not zacopride or GR38032F. Eur J Pharmacol 1992 Aug 6 1
29 1334113 Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. Int J Cell Cloning 1992 Nov 1
30 1345810 Mechanism of cross-resistance to a camptothecin analogue (CPT-11) in a human ovarian cancer cell line selected by cisplatin. Cancer Res 1992 Jan 15 6
31 1348364 High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A 1992 Apr 1 4
32 1350771 [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy]. Hokkaido Igaku Zasshi 1992 Mar 1
33 1353119 Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 1992 Aug 1
34 1354671 Restoration of proliferating cell nuclear antigen (PCNA) complex formation in xeroderma pigmentosum group A cells following cis-diamminedichloroplatinum (II)-treatment by cell fusion with normal cells. J Cell Physiol 1992 Sep 10
35 1355663 Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer 1992 Sep 2
36 1363120 Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals. J Pharmacobiodyn 1992 Sep 1
37 1370917 Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy. Cancer 1992 Feb 15 2
38 1371415 Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992 Mar 1 1
39 1372440 Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc Natl Acad Sci U S A 1992 Mar 15 2
40 1373636 POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity. Eur J Cancer 1992 1
41 1374316 Pharmacological agents affecting emesis. A review (Part I). Drugs 1992 Mar 1
42 1377669 The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma. Jpn J Cancer Res 1992 May 9
43 1380075 Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents. J Pediatr Surg 1992 Jun 1
44 1380890 Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. Cancer Res 1992 Sep 1 1
45 1381342 Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens. Jpn J Cancer Res 1992 Jul 1
46 1382047 Reoxygenation in the RIF-1 tumor after chemotherapy. Int J Radiat Oncol Biol Phys 1992 1
47 1382255 Combined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer. Oncology 1992 1
48 1384148 Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. Semin Oncol 1992 Apr 1
49 1384296 [Pure yolk sac tumor of the testis with brain metastasis: report of an adult case]. Hinyokika Kiyo 1992 Sep 1
50 1384952 Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity. Cancer 1992 Dec 1 1